Elevance Health Inc. ELV
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Stephen Baxter | Wells Fargo | 349.94 $ | 412 $ | 62.06 % | 07/10/2025 |
| David MacDonald | Truist Financial | 389.61 $ | 500 $ | 110.39 % | 09/06/2025 |
| David Windley | Jefferies | 430.77 $ | 529 $ | 98.23 % | 21/10/2024 |
| Whit Mayo | Leerink Partners | 430.77 $ | 515 $ | 84.23 % | 21/10/2024 |
| Sarah James | Raymond James | 432.53 $ | 485 $ | 52.47 % | 18/10/2024 |
| Ben Hendrix | RBC Capital | 444.35 $ | 478 $ | 33.65 % | 18/10/2024 |
| David MacDonald | Truist Financial | 444.35 $ | 520 $ | 75.65 % | 18/10/2024 |
| Michael Ha | Robert W. Baird | 483.87 $ | 625 $ | 141.13 % | 16/10/2024 |
| Ben Hendrix | RBC Capital | 502.06 $ | 585 $ | 82.94 % | 18/07/2024 |
| David MacDonald | Truist Financial | 535.54 $ | 620 $ | 84.46 % | 15/07/2024 |
| Erin Wright | Morgan Stanley | 534.42 $ | 643 $ | 108.58 % | 24/06/2024 |
| Michael Ha | Robert W. Baird | 505.52 $ | 649 $ | 143.48 % | 29/05/2024 |
| Ben Hendrix | RBC Capital | 525.19 $ | 575 $ | 49.81 % | 19/04/2024 |
| AJ Rice | UBS | 525.19 $ | 605 $ | 79.81 % | 19/04/2024 |
| Stephen Baxter | Wells Fargo | 525.19 $ | 600 $ | 74.81 % | 19/04/2024 |
| David Windley | Jefferies | 525.19 $ | 604 $ | 78.81 % | 19/04/2024 |
| Andrew Mok | Barclays | 525.19 $ | 621 $ | 95.81 % | 19/04/2024 |
| Joseph France | Loop Capital Markets | 454.76 $ | 550 $ | 95.24 % | 16/06/2022 |
| Stephen Baxter | Wells Fargo | 501.53 $ | 580 $ | 78.47 % | 25/05/2022 |
| Ben Hendrix | RBC Capital | 522.87 $ | 544 $ | 21.13 % | 21/04/2022 |
| Jonathan Yong | Credit Suisse | 522.87 $ | 584 $ | 61.13 % | 21/04/2022 |
| Michael Newshel | Evercore ISI | 529.84 $ | 335 $ | -194.84 % | 20/04/2022 |
| Ann Hynes | Mizuho Securities | 529.84 $ | 510 $ | -19.84 % | 20/04/2022 |
| David Windley | Jefferies | 529.84 $ | 625 $ | 95.16 % | 20/04/2022 |
| David MacDonald | Truist Financial | 510.64 $ | 590 $ | 79.36 % | 11/04/2022 |
| Kevin Caliendo | UBS | 489.34 $ | 541 $ | 51.66 % | 04/04/2022 |
| Matthew Borsch | BMO Capital | 434.61 $ | 510 $ | 75.39 % | 27/01/2022 |
| Lisa Gill | J.P. Morgan | 434.61 $ | 500 $ | 65.39 % | 27/01/2022 |
| Ben Hendrix | RBC Capital | 434.61 $ | 452 $ | 17.39 % | 27/01/2022 |
| Joseph France | Seaport Global | 427.24 $ | 480 $ | 52.76 % | 26/01/2022 |
| Michael Newshel | Evercore ISI | 427.24 $ | 335 $ | -92.24 % | 26/01/2022 |
| Lance Wilkes | Bernstein | 452.46 $ | 574 $ | 121.54 % | 11/01/2022 |
| Steve Baxter | Wells Fargo | 438.22 $ | 523 $ | 84.78 % | 06/01/2022 |
| Nathan Rich | Goldman Sachs | 432.72 $ | 517 $ | 84.28 % | 14/12/2021 |
| Justin Lake | Wolfe Research | 403.96 $ | 433 $ | 29.04 % | 30/11/2021 |
| Kevin Fischbeck | Bank of America Securities | 428 $ | 465 $ | 37.00 % | 21/10/2021 |
| Steven Valiquette | Barclays | 428 $ | 485 $ | 57.00 % | 21/10/2021 |
| A.J. Rice | Credit Suisse | 428 $ | 486 $ | 58.00 % | 21/10/2021 |
| Steven Halper | Cantor Fitzgerald | 421.68 $ | 470 $ | 48.32 % | 20/10/2021 |